Cargando…

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy

BACKGROUND: There is limited data on cerebrospinal fluid (CSF) biomarkers in sporadic amyloid-β (Aβ) cerebral amyloid angiopathy (CAA). OBJECTIVE: To determine the profile of biomarkers relevant to neurodegenerative disease in the CSF of patients with CAA. METHODS: We performed a detailed comparison...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerjee, Gargi, Ambler, Gareth, Keshavan, Ashvini, Paterson, Ross W., Foiani, Martha S., Toombs, Jamie, Heslegrave, Amanda, Dickson, John C., Fraioli, Francesco, Groves, Ashley M., Lunn, Michael P., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M., Werring, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242825/ https://www.ncbi.nlm.nih.gov/pubmed/32176643 http://dx.doi.org/10.3233/JAD-191254

Ejemplares similares

Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis
por: Banerjee, Gargi, et al.
Publicado: (2021)

Clinical considerations in early-onset cerebral amyloid angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2023)

Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios
por: Toombs, Jamie, et al.
Publicado: (2018)

Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
por: Paterson, Ross W., et al.
Publicado: (2018)

Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup
por: Woollacott, Ione O. C., et al.
Publicado: (2018)

Molecular biomarkers of Alzheimer's disease: progress and prospects
por: Lashley, Tammaryn, et al.
Publicado: (2018)

Minimally symptomatic cerebral amyloid angiopathy-related inflammation: three descriptive case reports
por: Banerjee, Gargi, et al.
Publicado: (2019)

Cognitive Impairment Before Intracerebral Hemorrhage Is Associated With Cerebral Amyloid Angiopathy
por: Banerjee, Gargi, et al.
Publicado: (2018)

Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest
por: Foiani, Martha S, et al.
Publicado: (2019)

Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles
por: Keshavan, Ashvini, et al.
Publicado: (2018)

Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
por: Paterson, Ross W., et al.
Publicado: (2015)

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy
por: Sembill, Jochen A, et al.
Publicado: (2023)

Convexity subarachnoid haemorrhage has a high risk of intracerebral haemorrhage in suspected cerebral amyloid angiopathy
por: Wilson, D., et al.
Publicado: (2017)

Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura
por: Banerjee, Gargi, et al.
Publicado: (2019)

The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice
por: Banerjee, Gargi, et al.
Publicado: (2017)

Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer’s Disease
por: van den Berg, Emma, et al.
Publicado: (2023)

Amyloid-beta 42 adsorption following serial tube transfer
por: Toombs, Jamie, et al.
Publicado: (2014)

CSF synaptic protein concentrations are raised in those with atypical Alzheimer’s disease but not frontotemporal dementia
por: Clarke, Mica T. M., et al.
Publicado: (2019)

Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?
por: Weston, Philip S.J., et al.
Publicado: (2016)

Cerebral Amyloid Angiopathy–Related Transient Focal Neurologic Episodes
por: Smith, Eric E., et al.
Publicado: (2021)

Cerebral Amyloid Angiopathy and the Risk of Hematoma Expansion
por: Seiffge, David J., et al.
Publicado: (2022)

Retinal amyloid angiopathy
por: Meira, Alex Tiburtino, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy: New Data and Quantitative Meta-Analysis
por: Margraf, Nils G., et al.
Publicado: (2022)

Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals
por: Paterson, R W, et al.
Publicado: (2014)

Gait in Cerebral Amyloid Angiopathy
por: Sharma, Breni, et al.
Publicado: (2022)

Cerebral amyloid angiopathy: an update
por: Schroeder, B. E., et al.
Publicado: (2023)

Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review
por: Theodorou, Aikaterini, et al.
Publicado: (2021)

Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease
por: De Kort, Anna M., et al.
Publicado: (2021)

Cerebral amyloid angiopathy related inflammation: An under recognized but treatable complication of cerebral amyloid angiopathy
por: Berry-Noronha, Alexander, et al.
Publicado: (2023)

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy
por: Jang, Young Kyoung, et al.
Publicado: (2017)

Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021)

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease
por: Kruse, Niels, et al.
Publicado: (2018)

Clinical features distinguish cerebral amyloid angiopathy-associated convexity subarachnoid haemorrhage from suspected TIA
por: Stanton, Joel Elliot Dane, et al.
Publicado: (2019)

The association between hypertensive angiopathy and cerebral amyloid angiopathy in primary intracerebral hemorrhage
por: Zhu, Yuyi, et al.
Publicado: (2023)

Superficial siderosis in cerebral amyloid angiopathy
por: Wani, Nisar Ahmad, et al.
Publicado: (2011)

Cerebral Amyloid Angiopathy: Emerging Concepts
por: Yamada, Masahito
Publicado: (2015)

Advances in cerebral amyloid angiopathy imaging
por: Chen, Szu-Ju, et al.
Publicado: (2019)

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
por: Gatti, Laura, et al.
Publicado: (2020)

Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
por: Keshavan, Ashvini, et al.
Publicado: (2020)

Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays
por: Keshavan, Ashvini, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bo5u4vpgli7o1hg7udt3t96off